1. Kelsell DP, Norgett EE, Unsworth H, et al. Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. Am J Hum Genet. 2005; 76:794–803.
2. Akiyama M, Sugiyama-Nakagiri Y, Sakai K, et al. Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J Clin Invest. 2005; 115:1777–1784.
Article
3. Thomas AC, Tattersall D, Norgett EE, O'Toole EA, Kelsell DP. Premature terminal differentiation and a reduction in specific proteases associated with loss of ABCA12 in Harlequin ichthyosis. Am J Pathol. 2009; 174:970–978.
Article
4. Dale BA, Kam E. Harlequin ichthyosis. Variability in expression and hypothesis for disease mechanism. Arch Dermatol. 1993; 129:1471–1477.
Article
5. Rajpopat S, Moss C, Mellerio J, et al. Harlequin ichthyosis: a review of clinical and molecular findings in 45 cases. Arch Dermatol. 2011; 147:681–686.
6. Toledo LC, Ger E. Evaluation of the operative treatment of syndactyly. J Hand Surg Am. 1979; 4:556–564.
Article
7. Vekris MD, Lykissas MG, Soucacos PN, Korompilias AV, Beris AE. Congenital syndactyly: outcome of surgical treatment in 131 webs. Tech Hand Up Extrem Surg. 2010; 14:2–7.
Article
8. Werner S, Krieg T, Smola H. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol. 2007; 127:998–1008.
Article
9. Overland J, Johnstone B. Surgical management of the hand manifestations of harlequin ichthyosis. ANZ J Surg. 2018; DOI:
10.1111/ans.14435. [Epub ahead of print].
Article